CREATE
TRANSFORMATIVE
MEDICINES
TRANSFORMATIVE
MEDICINES
PNI is a global leader in technology and solutions for developing RNA, DNA, CRISPR and small molecule drugs, rapidly taking ideas to patients.
Rapidly prepare low-volume nanoparticle formulations with the push of a button on the Spark™ or learn how Formulation Solutions can help with proof-of-concept nanoparticle formulations.
Optimize a wide range of nanomedicine formulations with the NanoAssemblr® Ignite or
the Blaze™
depending on your volumes to allow you to gather the data on the effectiveness, required dosing and safety of a new therapy.
Scalable manufacturing is a significant challenge to making revolutionary medicine and Clinical Solution is ready to assist you in your nanoparticle manufacturing process development.
Get Started
To learn how Precision NanoSystems accelerates nanomedicine development from an idea to clinical applications, contact our Technical Sales Team.
Technology
Our exclusive NxGen technology uses precisely controlled mixing to reproducibly generate optimal particles through a single mixer across scales. NxGen technology is at the heart of the NanoAssemblr® family, which provides manufacturing of nanoparticles at different scales suitable for all stages of nanomedicine development.
Coming Soon: The NanoAssemblr® Ignite
Areas of Interest
Nanomedicines span many areas of interest. Explore resourceslike papers, application notes, scientific posters, webinars and more to see how nanotechnology is transforming medicine.
over
70%
of top pharmaceutical companies work with PNI
200+
instruments are installed
worldwide
80+
biopharmaceutical labs use NanoAssemblr® instruments for nanomedicine
drug development
Innovations that accelerate the drug development journey and enable the production of more sophisticated and powerful nanomedicines is our passion. We don’t do it alone, we pursue strategic collaborations that enable researchers to move quickly
in the drug development process. Contact our Business Development Team.
PNI at 2019 BIO International Convention
Dr. James Taylor, CEO of Precision NanoSystems, successfully previewed NxGen microfluidic mixer by presenting on "How Precision NanoSystems’ NxGen Technology Drives the Creation of Transformative Nanomedicines” at the 2019 BIO International Convention.
License Agreement with Daiichi Sankyo
Daiichi Sankyo has signed a license agreement for use of the NanoAssemblr GMP System configuring a customized microfluidics-based GMP System that is fit-for-purpose and stage appropriate.
Clinical Solutions Platform Launch
“Clinical Solutions is designed to provide a one-stop-shop for all nanomedicine clinical development needs, such as sourcing GMP excipients, developing analytical methods, building Quality Management Systems or accessing experienced Contract Manufacturing Organizations,” Precision NanoSystems' CFO, Euan Ramsay
Resource Center
Publication - Summary
May 18, 2019
Annals of Hematology
Publication - Summary
May 17, 2019
Science Immunology
Publication - Summary
April 04, 2019
The Journal of Neuroscience
Publication - Summary
February 07, 2019
Nano Research
Application Note
January 16, 2019
Stay Informed
Sign up today to automatically receive new Precision NanoSystems application notes, conference posters, relevant science publications, and webinar invites.
MENU
菜单
